Patenting Antibody and Cell Therapies – What to Do and What Not to Do

In Webinars

28 September, 2020

Click here to watch webinar.

Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is a complex task, with constantly evolving case law and practice on both sides of the Atlantic. In this webinar, AWA’s experts focus on how to create, defend and litigate these patents in Europe and elsewhere.

 

 

You may also be interested in:

Opinions

China issues Opinions on destroying infringing and counterfeit goods

On August 13, 2020, nine of China’s authorities including the Supreme People’s Court and the State Administration for Market

Read more...
Criteria

CNIPA publishes trademark infringement criteria

To help strengthen and guide trademark law enforcement, provide uniform criteria for law enforcement, strengthen the protection of exclusive

Read more...

Nobel prize awarded to Crispr-patent tussle party Charpentier and Doudna

The Nobel committee has announced that this year’s prize in Chemistry is awarded to Doudna and Charpentier for their

Read more...

Mobile Sliding Menu